Inosine triphosphatase gene polymorphism and ribavirin-related anemia in chronic hepatitis C patients
Geng, J.-x.; Zhang, Q.; Zhang, J.-m.
Zhonghua Gan Zang Bing Za Zhi 20(12): 958-960
2012
ISSN/ISBN: 1007-3418 PMID: 23570062 Accession: 053880143
PDF emailed within 1 workday: $29.90
Related References
Nishimura, T.; Osaki, R.; Shioya, M.; Imaeda, H.; Aomatsu, T.; Takeuchi, T.; Okumura, Y.; Fujiyama, Y.; Andoh, A. 2012: Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients Molecular Medicine Reports 5(2): 517-520Rallón, N.I.; Morello, J.; Labarga, P.; Benito, J.é M.; Rodríguez-Nóvoa, S.; Vispo, E.; Barreiro, P.; Castro, M.Án.; Aguirrebengoa, K.; Pineda, J.A.; Miralles, P.; Tellez, M.J.ús.; Portu, J.ín.; Miralles, C.; Ocampo, A.; Soriano, V. 2011: Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 53(12): 1291-1295
Tanaka, Y.; Yokomori, H.; Otori, K. 2018: Induction of inosine triphosphatase activity during ribavirin treatment for chronic hepatitis C Clinica Chimica Acta; International Journal of Clinical Chemistry 482: 16-20
Tanaka, Y; Yokomori, H; Otori, K 2018: Induction of inosine triphosphatase activity during ribavirin treatment for chronic hepatitis C Clinica Chimica Acta 482: 16-20
Kozuka, R.; Hai, H.; Teranishi, Y.; Motoyama, H.; Kawamura, E.; Hagihara, A.; Uchida-Kobayashi, S.; Morikawa, H.; Enomoto, M.; Murakami, Y.; Kawada, N.; Tamori, A. 2017: Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy Journal of Gastroenterology and Hepatology 32(8): 1495-1502
DʼAvolio, A.; Ciancio, A.; Siccardi, M.; Smedile, A.; Baietto, L.; Simiele, M.; Marucco, D.A.; Cariti, G.; Calcagno, A.; de Requena, D.G.; Sciandra, M.; Cusato, J.; Troshina, G.; Bonora, S.; Rizzetto, M.; Di Perri, G. 2012: Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment Therapeutic Drug Monitoring 34(2): 165-170
Di Marco, V.; Calvaruso, V.; Grimaudo, S.; Ferraro, D.; Pipitone, R.M.; Di Stefano, R.; Craxì, A. 2013: Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices Journal of Viral Hepatitis 20(2): 113-121
Delvaux, Nália.; Costa, V.Duarte.da.; Costa, M.Matos.da.; Villar, L.Melo.; Coelho, H.Sérgio.Moraes.; Esberard, E.Bordalo.Cathalá.; Flores, P.Pollo.; Brandão-Mello, C.Eduardo.; Villela-Nogueira, C.Alves.; Almeida, A.José.de.; Lampe, E. 2015: Inosine triphosphatase allele frequency and association with ribavirin-induced anaemia in Brazilian patients receiving antiviral therapy for chronic hepatitis C Memorias do Instituto Oswaldo Cruz 110(5): 636-643
El Raziky, M.; Zayed, N.A.; Abdel Baki, A.; Mansour, S.A.; Shahin, R.M.H. 2017: ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C Journal of Medical Virology 89(10): 1823-1829
Nemr, N.; Kishk, R.; Mandour, M. 2016: Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 35(1): 7-13
Chi, X.; Wang, M.; Pan, Y.; Jiang, J.; Jiang, T.; Yan, H.; Wu, R.; Wang, X.; Gao, X.; Niu, J. 2020: Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon Journal of Gastroenterology and Hepatology 35(1): 97-103
Shen, T.T.; Zheng, C.; Xie, L.F.; Xu, L.L.; Zhang, Q. 2018: Association of ITPA gene variants and ribavirin-related anemia in Han Chinese with chronic hepatitis C genotype 1 infection Zhonghua Gan Zang Bing Za Zhi 26(6): 463-465
Murakawa, M.; Asahina, Y.; Nagata, H.; Nakagawa, M.; Kakinuma, S.; Nitta, S.; Kawai-Kitahata, F.; Otani, S.; Kaneko, S.; Miyoshi, M.; Tsunoda, T.; Asano, Y.; Sato, A.; Itsui, Y.; Azuma, S.; Nouchi, T.; Furumoto, Y.; Asano, T.; Chuganji, Y.; Tohda, S.; Watanabe, M. 2017: ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(11): 1212-1218
Murakawa, M.; Asahina, Y.; Nagata, H.; Nakagawa, M.; Kakinuma, S.; Nitta, S.; Kawai-Kitahata, F.; Otani, S.; Kaneko, S.; Miyoshi, M.; Tsunoda, T.; Asano, Y.; Sato, A.; Itsui, Y.; Azuma, S.; Nouchi, T.; Furumoto, Y.; Asano, T.; Chuganji, Y.; Tohda, S.; Watanabe, M. 2017: ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(11): 1212-1218
Asada, A.; Shioya, M.; Osaki, R.; Nishimura, T.; Takeuchi, T.; Okumura, Y.; Andoh, A. 2015: MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection Biomedical Reports 3(2): 247-253
Asadi-Saghandi, A.; Shams, A.; Eslami, G.; Mirghanizadeh, S.A.; Eskandari-Nasab, E. 2016: Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism Virusdisease 27(4): 369-374
Clark, P J.; Aghemo, A; Degasperi, E; Galmozzi, E; Thompson, A J.; Patel, K; Rumi, M Grazia; Prati, G.; Colombo, M 2012: Sa1093 Inosine Triphosphastase (ITPA) Variants Predict Treatment-Induced Anemia, Ribavirin Dose-Reduction and Need for Erythropoietin Support During Peginterferon/Ribavirin Therapy for Chronic HCV Gastroenterology 142(5): S-967-S-968
Tsubota, A.; Shimada, N.; Abe, H.; Yoshizawa, K.; Agata, R.; Yumoto, Y.; Ika, M.; Namiki, Y.; Nagatsuma, K.; Matsudaira, H.; Fujise, K.; Tada, N.; Aizawa, Y. 2012: Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C World Journal of Gastroenterology 18(41): 5879-5888
Shioya, M.; Asada, A.; Osaki, R.; Nishimura, T.; Nishida, A.; Inatomi, O.; Bamba, S.; Andoh, A. 2015: Su1413 Micb (Mhc Class I-Related Chain B) Gene Polymorphism Is Associated With Virological Response to Pegylated Interferon Plus Ribavirin Therapy in Patients With Chronic Hepatitis C Infection Gastroenterology 148(4): S-502
Kurosaki, M.; Tanaka, Y.; Tanaka, K.; Suzuki, Y.; Hoshioka, Y.; Tamaki, N.; Kato, T.; Yasui, Y.; Hosokawa, T.; Ueda, K.; Tsuchiya, K.; Kuzuya, T.; Nakanishi, H.; Itakura, J.; Takahashi, Y.; Asahina, Y.; Matsuura, K.; Sugauchi, F.; Enomoto, N.; Nishida, N.; Tokunaga, K.; Mizokami, M.; Izumi, N. 2011: Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin Antiviral Therapy 16(5): 685-694